MHI Advisory | Specialists in metabolic health

Specialist insight

for

metabolic

health

for organizations whose decisions shape how metabolic healthcare is developed, delivered, evaluated and financed.

THE PROBLEM WE ADDRESS

In metabolic disease, the problem isn't a lack of solutions. It's solutions that see only part of the problem.

Obesity, diabetes and their complications involve many factors and stakeholders. Single-discipline or treatment-specific approaches miss the wider picture. MHI integrates these perspectives into advice that works across clinical, economic and policy contexts.

ORGAN SYSTEMS

The disease crosses organ systems

It affects the liver, heart, kidneys and more. No single specialty sees the whole patient.

DISCIPLINES

The advice must cross fields

The answer sits between medicines, surgery, nutrition, behavioural care and other professions.

STAKEHOLDERS

Each sees a different part

Clinicians, patients, payers, industry and policymakers weigh different outcomes and risks.

EVIDENCE

Incomplete and often contested

Credible experts read the same data differently. Good advice is not one view or their sum, but what holds once each is tested.

Seeing the whole problem takes all of these perspectives at once.
That is what MHI is built to do.

GLOBAL AND LOCAL BY DESIGN

Obesity is a global problem. Every solution is applied locally.

A regional pathway, a single trial or one market decision can look like a local, focused question. It rarely is. The best answers learn from the bigger picture while staying grounded in local realities, and neither view is enough on its own.

ZOOM OUT

The Bigger Picture

Global evidence, trends and lessons: what has worked, and failed, across countries, health systems and disciplines.

ZOOM IN

The Focused Question

Global evidence, trends and lessons: what has worked, and failed, across countries, health systems and disciplines.

Global in perspective. Local in practice. Whatever the size question.

WHO WE WORK WITH

Organizations whose decisions shape metabolic health

Six groups that determine how care for obesity, diabetes and metabolic disease is developed, delivered, funded and governed.

Develop Pharma, biotech and medtech Innovate Digital health and health tech Deliver Hospitals, clinics and providers Fund Health systems and payers Invest Investors and private capital Govern Public and professional bodies

FROM EXPERIENCE TO ETHOS

Our story built the method. Our founders and advisors set the standard. The experts we engage bring the depth.

Together the founding team forms MHI’s advisory board. MHI also draws on world-leading clinicians, researchers, trialists, health economists, policy experts and patient representatives, engaged for each question.

see More About us

WHAT WE DO

Services scaled to the question, with one standard of rigor throughout.

A few senior experts on a focused commission

SCALED TO THE QUESTION0%

A multidisciplinary international group

Long-term value for all customers

New York Office